▶ 調査レポート

経頭蓋ドップラー超音波の世界市場:成長・動向・市場規模予測(2020-2025)

• 英文タイトル:Transcranial Doppler Ultrasound Market - Growth, Trends, and Forecast (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。経頭蓋ドップラー超音波の世界市場:成長・動向・市場規模予測(2020-2025) / Transcranial Doppler Ultrasound Market - Growth, Trends, and Forecast (2020 - 2025) / D0-MOR-AP1159資料のイメージです。• レポートコード:D0-MOR-AP1159
• 出版社/出版日:Mordor Intelligence / 2020年4月20日
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:健康管理
• 販売価格(消費税別)
  Single User¥629,000 (USD4,250)▷ お問い合わせ
  Team User¥703,000 (USD4,750)▷ お問い合わせ
  Corporate License¥1,110,000 (USD7,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、経頭蓋ドップラー超音波の世界市場について調査・分析した資料で、経頭蓋ドップラー超音波の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。

The Transcranial Doppler Ultrasound Market is expected to register a CAGR of 6% during the forecast period. This is attributing to technological innovation coupled with high investment in health care and an increasing rate of diseases that required ultrasound to be done. Moreover, increasing neurological disorders and a large number of applications associated with this system are making it possible to use it for over large range. Technological advancements such as the use of greyscale, spectral Doppler and color doppler flow imaging directly visualize intracranial vessels, thus simplifying flow velocity measurements and enhancing the accuracy for vasospasm detection.
However, the absence of an acoustic window coupled with low spatial resolutions may hinder the market growth to a certain extent.

Key Market Trends

Applications of Transcranial Doppler Ultrasound System in Sickle cell diseases are expected to witness a healthy growth in future

The population affected with Sickle cell diseases is more likely to use this system for ultrasound. This disease is a hereditary blood disorder characterized by abnormal, rigid, sickle-shaped red blood cells caused due to mutations. As per the National Institute of Health (NIH), Sickle cell diseases are the most common inherited disorders in the United States affecting more than 70,000 Americans leading to the adoption of transcranial doppler ultrasound by the targeted patient pool for identifying the diseases. This high demand for transcranial Doppler ultrasound system for screening purposes in the targeted population will lead to driving the market.

In Addition, with an increasing number of neurological disorders worldwide, there is going to be an increase in the adoption of this system for evaluating cerebral hemodynamics and diagnose cerebrovascular disorders and thus results promote the growth of the overall market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global Transcranial Doppler Ultrasound System Market due to rising incidences of neurological disorders and increasing geriatric population as these populations need a constant diagnosis to be done. Moreover, high health care infrastructure with an increasing rate of cardiovascular diseases will also boost revenue growth in this region.

Competitive Landscape

The market studied is moderately competitive and there are several international as well as local companies in the market. Some of the companies which are currently dominating the Transcranial Doppler Ultrasound System Markets market are Neural Analytics, Viasonix, Rimed, B. Braun Melsungen AG, Konica Minolta Healthcare India Pvt. Ltd. and Spencer Technologies.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing preference for transcranial doppler in detecting various cerebrovascular diseases
4.2.2 Technological Advancements
4.3 Market Restraints
4.3.1 Lack of Skilled Expertise
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Application
5.1.1 Sickle Cell Disease
5.1.2 Acute Ischemic Stroke
5.1.3 Intracranial Steno Occlusive Disease
5.2 By End User
5.2.1 Hospitals
5.2.2 Diagnostic Laboratories
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Neural Analytics
6.1.2 Viasonix
6.1.3 Rimed
6.1.4 B. Braun Melsungen AG
6.1.5 Konica Minolta Healthcare India Pvt. Ltd.
6.1.6 Spencer Technologies

7 MARKET OPPORTUNITIES AND FUTURE TRENDS